Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Moser

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Molecular Cancer Therapeutics|September 3, 2011
Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancerJohannes Taeger, Christian Moser, Claus Hellerbrand, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in miceSven A Lang, Christian Moser, Stefan Fichnter-Feigl, et al.
Molecular Cancer Therapeutics|November 13, 2008
Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytesSven A Lang, Philipp Schachtschneider, Christian Moser, et al.
Molecular Cancer Therapeutics|November 21, 2007
Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivoChristian Moser, Sven A Lang, Silvia Kainz, et al.
BMC Cancer|December 7, 2010
Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibitionChristina Hackl, Sven A Lang, Christian Moser, et al.
Mbio|June 4, 2015
Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in MiceEva Pericolini, Elena Gabrielli, Mario Amacker, et al.
Surgery|December 18, 2009
Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental modelsChristina Hackl, Akira Mori, Christian Moser, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 20, 2017
Virosome-bound antigen enhances DC-dependent specific CD4<sup>+</sup> T cell stimulation, inducing a Th1 and Treg profile in vitroRebecca A M Blom, Mario Amacker, Christian Moser, et al.
Clinical Hemorheology and Microcirculation|December 29, 2012
Contrast-enhanced ultrasound (CEUS) detects effects of vascular disrupting therapy in an experimental model of gastric cancerSven A Lang, Christian Moser, Sebastian Gehmert, et al.
Molecular Cancer Therapeutics|March 17, 2007
Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivoSven A Lang, Dagmar Klein, Christian Moser, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|September 3, 2011
Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancerJohannes Taeger, Christian Moser, Claus Hellerbrand, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in miceSven A Lang, Christian Moser, Stefan Fichnter-Feigl, et al.
Molecular Cancer Therapeutics|November 13, 2008
Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytesSven A Lang, Philipp Schachtschneider, Christian Moser, et al.
Molecular Cancer Therapeutics|November 21, 2007
Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivoChristian Moser, Sven A Lang, Silvia Kainz, et al.
BMC Cancer|December 7, 2010
Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibitionChristina Hackl, Sven A Lang, Christian Moser, et al.
Mbio|June 4, 2015
Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in MiceEva Pericolini, Elena Gabrielli, Mario Amacker, et al.
Surgery|December 18, 2009
Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental modelsChristina Hackl, Akira Mori, Christian Moser, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 20, 2017
Virosome-bound antigen enhances DC-dependent specific CD4<sup>+</sup> T cell stimulation, inducing a Th1 and Treg profile in vitroRebecca A M Blom, Mario Amacker, Christian Moser, et al.
Clinical Hemorheology and Microcirculation|December 29, 2012
Contrast-enhanced ultrasound (CEUS) detects effects of vascular disrupting therapy in an experimental model of gastric cancerSven A Lang, Christian Moser, Sebastian Gehmert, et al.
Molecular Cancer Therapeutics|March 17, 2007
Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivoSven A Lang, Dagmar Klein, Christian Moser, et al.
Pageof 6